TMEM174 | Transmembrane protein 174 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
UMOD | Uromodulin | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Group enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
KNG1 | Kininogen 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HAO2 | Hydroxyacid oxidase 2 (long chain) | Enzymes
| | | | | Group enriched |
CYP4A22 | Cytochrome P450, family 4, subfamily A, polypeptide 22 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Group enriched |
MCCD1 | Mitochondrial coiled-coil domain 1 | Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC34A1 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CYP4A11 | Cytochrome P450, family 4, subfamily A, polypeptide 11 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | | | Group enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A6 | Solute carrier family 22 (organic anion transporter), member 6 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC7A13 | Solute carrier family 7 (anionic amino acid transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A11 | Solute carrier family 22 (organic anion/urate transporter), member 11 | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
NPHS2 | Nephrosis 2, idiopathic, steroid-resistant (podocin) | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MIOX | Myo-inositol oxygenase | Enzymes
| | | | | Tissue enriched |
SLC36A2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Transporters
| | | | | Tissue enriched |
CLDN19 | Claudin 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | | | | | | Group enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A7 | Solute carrier family 22 (organic anion transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM207 | Transmembrane protein 207 | Predicted membrane proteins
| | | | | Tissue enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes
| | | | | Group enriched |
POU3F3 | POU class 3 homeobox 3 | Transcription factors
| | | | | Group enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AL138847.1 | CDNA FLJ26506 fis, clone KDN07105; Uncharacterized protein | Predicted secreted proteins
| | | | | Group enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | | | | Group enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM213 | Transmembrane protein 213 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CUBN | Cubilin (intrinsic factor-cobalamin receptor) | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | | | | Group enriched |
UGT2A2 | UDP glucuronosyltransferase 2 family, polypeptide A2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |